Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bright Way Group is a Russian pharmaceutical holding company focused on the development, manufacture, distribution, and foreign trade of finished medicines and pharmaceutical substances. The group includes Velpharm, a manufacturing company in Kurgan; Veltrade, a pharmaceutical distributor in Russia and the CIS; Bright Way LLC, which handles foreign economic activity; and Bright Way Industries/Velpharm-M, a newer manufacturing site in Zelenograd. Publicly available materials indicate the group markets a portfolio of commercial medicines, with additional products under registration and development, and emphasizes affordable, domestically manufactured drugs. Its product mix appears concentrated in conventional generic and branded-generic therapeutics across multiple primary care categories rather than novel targeted biologics. The company also promotes contract, licensed, and private-label production capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bright Way Group.